The Food and Drug Administration (FDA) of the Philippines has announced a significant voluntary product recall affecting popular infant and child milk formulas. Nestlé Philippines, Inc. is pulling fourteen specific variants of its Nan Optipro and Nankid Optipro products from the market, a move initiated as a precautionary measure to safeguard consumer health.
Scope of the Recall: Which Products Are Affected?
According to the official FDA Advisory No. 2026-0030, published on January 16, 2026, the recall encompasses a total of 14 different product variants spanning 38 specific batch numbers. The affected items include formulas designed for infants from 0 to 6 months, follow-on milk for babies 6 to 12 months, and milk supplements for toddlers and children aged 1 to 3 years and 3 years and above.
The complete list of recalled packaging includes:
- NAN OPTIPRO 0-6 months Infant Formula 5HMO 3 (4x600g)
- NAN OPTIPRO 0-6 months Infant Formula 5HMO 6 (2x650g)
- NAN OPTIPRO 0-6 months Infant Formula 5HMO 6x400g
- NAN OPTIPRO 0-6 months Infant Formula 5HMO 6 (2x450g)
- NAN OPTIPRO 6-12months Follow On 5HMO 3 (4x600g)
- NAN OPTIPRO 6-12months Follow On 5HMO 6 (2x450g)
- NAN OPTIPRO 6-12months Follow On 5HMO 6x400g
- NAN OPTIPRO 6-12months Follow On 5HMO 6 (2x650g)
- NAN OPTI 1-3Yrs Milk Supplement 5HMO 3 (4x600g)
- NAN OPTI 1-3Yrs Milk Supplement 5HMO 4 (4x600g)
- NAN OPTI 1-3Yrs Milk Supplement 5HMO 6 (2x450g)
- NAN OPTI 1-3Yrs Milk Supplement 5HMO 6x400g
- NANKID OPTIPRO 3+ Yrs 5HMO 3 (4x600g)
- NANKID OPTIPRO 3+ Yrs 5HMO 3 (2x650g)
The regulatory body was quick to clarify that this recall applies only to the specific batches identified by the company. Other Nan Optipro and Nankid Optipro products not listed are not part of this action and remain safe for consumption.
Reason Behind the Precautionary Measure
The decision for the voluntary recall stems from quality control testing. The FDA stated that the action followed the detection of very low levels of cereulide in an ingredient used in the products.
"Cereulide is a toxin produced by the microorganism Bacillus cereus and may cause gastrointestinal illness, such as vomiting and abdominal pain," the FDA explained in its advisory. The trace amounts were found in the arachidonic acid-rich (ARA) oil supplied to Nestlé for manufacturing.
No Reported Illnesses, Action is Precautionary
Emphasizing the proactive nature of the recall, both Nestlé Philippines and the FDA confirmed that there have been no reports of associated illnesses or adverse events linked to the identified batches to date.
This voluntary recall is purely a precautionary measure undertaken by the company in collaboration with the health authority to ensure the highest safety standards and protect Filipino consumers, particularly vulnerable infants and young children. Parents and guardians who have purchased any of the listed products are advised to check the batch numbers on the packaging and refrain from using them. They should contact Nestlé Philippines directly for instructions on returns or further inquiries regarding product safety.
